By Momo Yamamoto, Investor Research Analyst, LSN
Time is flying by, and there is only a month left until RESI Boston! As a refresher, RESI Boston will be a 3-day hybrid conference, taking place on June 5th – 7th. June 5th will be in-person at the Westin Copley Place, featuring Innovator’s Pitch Challenge (IPC) sessions, 7 investor panels, and educational workshops followed by all-day virtual partnering on June 6th – 7th.
Life Science Nation is excited to announce the 20+ panelists who have been selected to speak on our investor panels at RESI Boston. Panel topics include: Big Pharma, Women’s Health, Cell & Gene Therapy, Corporate VC, CNS Diseases, Medtech Strategics, and Digital Health. At this RESI, we will be featuring two new panel topics, Women’s Health and CNS Diseases. Join our seasoned panelists from a wide range of sectors to get the latest insight on trends, emerging topics, advice, and more!
Take a look below for our panelists who will be giving you the latest scoop:
 Elizabeth Bailey Managing Director RH Capital |
 Caleb Bell Venture Partner Corundum Systems Biology |
 Nat Brinn Partner VC23 |
 Frederic Cedrone Vice President, Corporate Innovation Catalent Strategic Ventures |
 Geoff Dacosta Director, Business Development and Licensing Philips Healthcare |
 Neel Desai Business Development & Licensing Biogen |
 Marissa Fayer U.S. Partner Goddess Gaia Ventures |
 Tom Gibbs Director Debiopharm Innovation Fund |
 Lucio Iannone VP of Investments Leaps by Bayer |
 Jotthe Kannappan Associate Intuitive Surgical |
 Arianne Kidder Principal Seae Ventures |
 Joan Koerber-Walker Co-Founder and Managing Member AZBio |
 Adam Kundzewicz Executive Director Boehringer Ingelheim Venture Fund |
 Linda Li Venture Partner Cleveland Clinic Ventures |
 Wasim Malik Co-Founder and Managing Partner Iaso Ventures |
 Amanda Mason Director, Global Head of Inflammation Search & Evaluation, Business Development Amgen |
 John Pennett Angel Investor Mid Atlantic Bio Angels |
 Jane Rho Investor, Venture Fund DaVita Venture Group |
 Ronak Savla Director, Strategic Ventures Catalent Strategic Ventures |
 Yaniv Sneor Founding Member Mid Atlantic Bio Angels |
 Ashim Subedee Director, Catalyst Office Division of Research Innovation and Ventures (DRIVe) |
 David Uffer Vice President, MedTech General Inception |
 Matt Weinberg Partner Max Ventures |
 Sonia Weiss Co-Founder & Managing Partner WPSS.bio |
 Andrew Wong Global Head of Bayer CoLabs Bayer |
 Lu Zhang Managing Partner Fusion Fund |
Next Phase Newsletter 
Leave a comment